首页> 外国专利> New and known 3-azido-nucleoside(s) - useful for therapy of viral and bacterial infections esp. HIV retro-viral infections and resistant gram negative bacterial infections

New and known 3-azido-nucleoside(s) - useful for therapy of viral and bacterial infections esp. HIV retro-viral infections and resistant gram negative bacterial infections

机译:新的和已知的3-叠氮核苷-特别适用于治疗病毒和细菌感染。 HIV逆转录病毒感染和耐药革兰氏阴性细菌感染

摘要

(1) 3-Azido-nucleosides of formula (I) and their derivs. are new. A'=purine or pyrimidine base linked at the 9- or 1-position, other than (a) (I) where A'=adenine, guanine, uridine, cytidine or thymine base, and their 5'-mono and 5'-triphosphate esters, (b) the 5'-O-acetate, 5'-O-trityl and 5'-O-(4-methylbenzenesulphonate) derivs. of cpds. where A'=uridine base and the 3'=N3 is in the erythro configuration (c) (I) where A'=5-bromovinyluridine or 5-trifluoromethyluridine residue and the 3'-N3 is in the erythro configuration or A'=uridine residue and the 3'-N3 is in the threo configuration or A'=uridine residue and the 3'-N3 is in the threo configuration or A'=5-iodo- or 5-fluoro-uridine residue and the 3'-N3 is in the erythro or threo configuration and the 5' -O-trityl derivs. of such cpds. (d) (I) where A'=5-bromovinyl uridine or cytidine residue and the 3'-N3 is in the threo configuration or A'=5-fluorocytidine residue and the 3'-N3 is in the erythroconfiguration or A'=5-methylcytidine residue and the 3'-N3 is in the threo or erythro configuration (e) the 5'-O-acetate of (I) where A'=4-chloro-2(1H)-pyrimidone or 4-(1H-1,2,4-triazol-1-yl)-2(1H)-pyrimidone (opt. 5-substd. by F or Me) and the 3'-N3 is in the erythro configuration (f) the 5'-O-((4-methoxyphenyl) diphenylmethyl) deriv. of (I) where A'=cytidine residue and the 3'-N3 is in the erythro configuration and (g) the 5'-O-trityl deriv. of (I) where A'=adenine residue and the 3'-N3 gp. is in the threo configuration. (2) 3-Azido nucleosides of formula (II) and their derivs. are new for use in human or veterinary therapy. A=purine or pyrimidine base, other than thymine, linked at the 9-or 1-position.
机译:(1)式(I)的3-叠氮基核苷及其衍生物。是新的。除(a)(I)以外,A'=在9或1位连接的嘌呤或嘧啶碱基,其中A'=腺嘌呤,鸟嘌呤,尿苷,胞苷或胸腺嘧啶碱基,及其5'-单和5'-三磷酸酯,(b)5'-O-乙酸酯,5'-O-三苯甲基和5'-O-(4-甲基苯磺酸酯)衍生。 cpds。其中A'=尿苷碱基且3'= N3为赤型构型(c)(I)其中A'= 5-溴乙烯基尿苷或5-三氟甲基尿苷残基且3'-N3为赤型构型或A'=尿苷残基和3'-N3为苏氨酸构型或A'=尿苷残基,而3'-N3为苏氨酸构型或A'= 5-碘或5-氟尿苷残基,且3'- N 3为赤或苏构型,并且5'-O-三苯甲基衍生。此类cpds。 (d)(I),其中A'= 5-溴乙烯基尿苷或胞苷残基,并且3'-N3处于苏氨酸构型或A'= 5-氟胞苷残基,并且3'-N3处于赤型构型或A'= 5-甲基胞嘧啶残基和3'-N3为苏或赤型构型(e)(I)的5'-O-乙酸盐,其中A'= 4-氯-2(1H)-嘧啶酮或4-(1H -1,2,4-三唑-1-基)-2(1H)-嘧啶酮(由F或Me选择5-取代),且3'-N3为赤型构型(f)5'- O-((4-甲氧基苯基)二苯甲基)衍生物。 (I)其中A'=胞苷残基,3'-N3为赤型构型,(g)5'-O-三苯甲基衍生物。 (I)中的A′=腺嘌呤残基和3′-N3 gp。在threo配置中。 (2)式(II)的3-叠氮基核苷及其衍生物。是用于人或兽医疗法的新药。除了胸腺嘧啶以外,A =在9或1位连接的嘌呤或嘧啶碱基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号